查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1806182

局部給藥市場按產品類型、給藥技術、給藥途徑、劑型、治療用途、最終用戶和分銷管道分類 - 全球預測 2025-2030

Topical Drug Delivery Market by Product Type, Delivery Technology, Route of Administration, Formulation Type, Therapeutic Application, End User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年局部給藥市值為 1,841.3 億美元，預計 2025 年將成長至 1,967.6 億美元，複合年成長率為 7.06%，到 ​​2030 年將達到 2,772.8 億美元。

主要市場統計數據
基準年2024年 1841.3億美元
預計2025年 1967.6億美元
預測年份 2030 2772.8億美元
複合年成長率（%） 7.06%

隨著患者期望的提高和技術的進步，為局部給藥解決方案建立策略背景

直接應用於皮膚的治療方法的快速發展正在改寫藥物傳遞的敘事，將靶向療效和患者便利性推向了醫藥創新的前沿。乳膏、凝膠、軟膏和貼片等局部產品已日趨成熟，不再局限於簡單的配方，而是融入了先進的分子載體和智慧釋放技術，從而最佳化吸收，同時最大限度地減少全身暴露。這種轉變的促進因素包括：慢性皮膚病的盛行率不斷上升、局部疼痛管理需求的不斷成長，以及透過易於使用的劑型來提高患者依從性。

闡明模式轉移，透過先進的交付機制和以患者為中心的設計推動局部治療的創新

近年來，在以患者為中心的設計與尖端材料科學融合的推動下，局部給藥領域發生了根本性轉變。微結構脂質載體和聚合物奈米凝膠等創新技術實現了控釋特性和更高的滲透性，從而實現了傳統半固態製劑所不具備的穩定療效。同時，數位健康的融合也推動了穿戴式感測器在經皮吸收貼片中的應用，從而能夠即時監測藥物依從性和皮膚狀態動態。

2025年美國新關稅政策對外用藥物製造供應鏈和成本結構的廣泛影響分析

美國計劃於2025年實施的新關稅正在重塑外用藥品生產和分銷的經濟格局。從海外供應商採購原料藥和輔料的製造商面臨進口關稅上調，這將對採購和庫存管理流程產生連鎖反應。這些成本壓力正在推動供應鏈重組，企業正在重新審視其供應商組合，並評估近岸外包生產的可行性，以降低關稅波動的影響。

深入研究局部給藥的關鍵市場領域，涵蓋各種產品類型、配方技術和治療應用

對市場區隔的細緻理解，揭示了產品創新和商業性應用背後的市場驅動力。根據產品類型，局部製劑包括含油包水乳化劑和水包油乳化劑的乳膏，每種乳膏都因其獨特的皮膚保濕和屏障調節特性而被選中。凝膠包括水凝膠系統，其擅長清涼保濕，以及有機凝膠系統，其促進親油性藥物的分散。軟膏分為親水性和親油性基質，可容納水溶性和油溶性活性成分。貼片種類繁多，從適合即時釋的單層層級構造到旨在緩釋的複雜多層結構。

探索影響美洲、歐洲、中東、非洲和亞太地區局部治療解決方案採用和創新的區域動態

醫療保健基礎設施、管理體制和患者人口統計的地區差異顯著影響著外用藥物的採用和創新軌跡。美洲擁有強大的皮膚病治療產品線，並由精簡的核准流程和成熟的專科診所網路提供支持，這些網路支持先進的製劑。北美的報銷政策獎勵了具有成本效益的解決方案，而拉丁美洲市場不斷擴展的公共衛生舉措則推動了對價格實惠的學名藥和生物學名藥的需求。

剖析透過策略創新夥伴關係和擴張推動局部給藥市場成長和差異化的產業領導者

產業領導者透過策略聯盟、專有技術平台和廣泛的製劑組合實現差異化。大型製藥集團利用其內部研發能力，開發整合感測器或採用響應式釋放機制的下一代外用系統。全球規模和監管專業知識使其能夠快速進入關鍵市場，並促進複雜的臨床評估。

概述產業領導層面臨的策略挑戰和戰術性舉措，以提高局部給藥領域的市場定位和營運效率

為了充分利用不斷變化的市場動態，行業領導者必須採取多管齊下的方法，使研發投資與不斷變化的患者和付款人的優先事項保持一致。高階主管應優先開發整合數位化依從性監測和響應式釋放觸發機制的智慧交付系統。透過組成融合製藥科學家、材料工程師和數據分析師的多學科團隊，組織可以加速概念驗證研究，並降低先進研發管線候選藥物的風險。

我們嚴謹的研究框架和分析方法的詳細資訊，採用定性和定量方法來確保全面的市場洞察

本摘要中提出的見解源自於精心建構的研究通訊協定，該方案結合了定性和定量方法。與關鍵意見領袖（包括皮膚科醫生、藥理學家和製劑科學家）進行的初步探索性訪談，為未滿足的需求和技術障礙提供了基礎觀點。這些主要資訊也輔以同行評審日誌、專利資料庫和會議論文集的系統性綜述，以捕捉最新的科學突破和監管發展。

綜合核心見解和未來觀點，指導相關人員克服局部給藥領域的機會與挑戰

這篇全面的分析凸顯了局部給藥領域的關鍵時刻：技術創新、法規演變和患者期望的不斷變化共同重塑了競爭格局。先進的給藥機制開啟了新的治療領域，永續性和數位化整合重新定義了超越傳統藥物動力學參數的價值，而關稅和貿易政策的不利因素凸顯了敏捷性和本地製造的重要性，因此需要製定適應性供應鏈策略。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 奈米乳劑技術進展增強生技藥品的皮膚滲透性
  • 越來越多人採用微針貼片進行無痛自我治療
  • 緩釋性聚合物基質整合到局部創傷治療配方中
  • 可客製化經皮給藥系統的 3D 列印技術的出現
  • 協調局部奈米載體核准國際指南的監理挑戰
  • 著重以病人為中心的設計，以提高局部皮膚病治療的依從性
  • 胜肽穩定策略的進展可提高乳霜的皮膚生物有效性

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

8. 局部給藥市場（依產品類型）

  • 奶油
    • 水包油
    • 油中含水
  • 凝膠
    • 水凝膠
    • 有機凝膠
  • 軟膏
    • 親水性
    • 親油性的
  • 修補
    • 多層
    • 單層

第9章局部給藥市場：給藥技術

  • 主動交付
  • 被動交付

第10章局部給藥市場（依給藥途徑）

  • 頰粘膜
  • 皮膚
  • 鼻腔
  • 眼科
  • 直腸
  • 陰道

第 11 章。局部給藥市場（按劑型）

  • 液體
  • 半固態
  • 固體的
  • 噴霧和泡沫

第 12 章。按治療用途分類的局部給藥市場

  • 皮膚科
    • 抗菌
    • 抗真菌
    • 消炎（藥）
  • 荷爾蒙補充療法
    • 雌激素
    • 睪固酮
  • 疼痛管理
    • 局部麻醉劑
    • NSAIDs

第 13 章。局部給藥市場（按最終用戶分類）

  • 診所
  • 家庭醫療保健
  • 醫院
    • 住院病人
    • 門診
  • 零售藥局

第 14 章。局部給藥市場（按分銷管道）

  • 離線
    • 醫院藥房
    • 零售藥局
  • 網路藥局

15. 美國局部給藥市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

16. 歐洲、中東和非洲局部給藥市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

17. 亞太地區局部給藥市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第18章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • DuPont de Nemours, Inc.
    • Element Materials Technology
    • 3M Company
    • AbbVie Inc.
    • Bausch Health Companies Inc.
    • Bayer AG
    • Crescita Therapeutics Inc.
    • Galderma SA
    • GlaxoSmithKline plc
    • Hisamitsu Pharmaceutical Co.,Inc.
    • Johnson & Johnson Services, Inc.
    • Kindeva Drug Delivery LP
    • LEO Pharma A/S
    • Lubrizol Corporation
    • MedPharm Group Ltd.
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer Inc.
    • Porex Corporation
    • Sun Pharmaceutical Industries Ltd.

第19章 研究人工智慧

第20章 研究統計

第21章 研究聯絡人

第22章 研究報導

第23章 附錄

Product Code: MRR-4316E4E89103

The Topical Drug Delivery Market was valued at USD 184.13 billion in 2024 and is projected to grow to USD 196.76 billion in 2025, with a CAGR of 7.06%, reaching USD 277.28 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 184.13 billion
Estimated Year [2025] USD 196.76 billion
Forecast Year [2030] USD 277.28 billion
CAGR (%) 7.06%

Establishing the Strategic Context for Topical Drug Delivery Solutions Amid Evolving Patient Expectations and Technological Advancements

The rapid evolution of therapeutic interventions applied directly to the skin is rewriting the narrative of drug delivery, bringing targeted efficacy and patient convenience to the forefront of pharmaceutical innovation. Topical applications such as creams, gels, ointments, and patches have matured beyond simple formulations, embracing advanced molecular carriers and smart-release technologies that optimize absorption while minimizing systemic exposure. This shift is driven by increasing prevalence of chronic dermatological conditions, growing demand for localized pain management, and a broader emphasis on improving patient adherence through user-friendly dosage forms.

Concurrently, research breakthroughs in transdermal transport mechanisms, from microneedle arrays to iontophoretic enhancers, are broadening the spectrum of molecules that can be administered noninvasively. Regulatory frameworks have adapted to accommodate these innovations, streamlining pathways for approval while maintaining rigorous safety and efficacy standards. As a result, stakeholders across the pharmaceutical value chain are reimagining manufacturing practices, supply chain configurations, and commercial strategies to capture emerging opportunities.

This executive summary sets the stage for a detailed analysis of the transformative shifts, tariff implications, segmentation dynamics, regional drivers, competitive landscapes, and research methodologies that will shape the future of topical drug delivery. Through an integrated perspective, it provides decision-makers with the clarity needed to navigate a complex market and capitalize on the next wave of therapeutic advancements.

Uncovering the Paradigm Shifts Driving Innovation in Topical Therapeutics Through Advanced Delivery Mechanisms and Patient-Centric Design

Over the last several years, the topical drug delivery landscape has undergone a fundamental transformation, propelled by convergence of patient-centric design and cutting-edge materials science. Innovations such as microstructured lipid carriers and polymeric nanogels are enabling controlled release profiles and enhanced permeation, providing consistent therapeutic outcomes where traditional semi-solid forms once fell short. In parallel, digital health integration has introduced wearable sensors into transdermal patches, empowering real-time monitoring of dosing adherence and skin condition dynamics.

Moreover, ethical and environmental imperatives are driving a shift toward biodegradable excipients and eco-friendly packaging. Developers are increasingly harnessing botanical actives and green surfactants to meet consumer demand for clean-label formulations, forging stronger connections with end users who seek transparency and sustainability. This movement dovetails with intensified collaboration between academic research institutions and contract development organizations, accelerating the translation of novel delivery concepts from bench to manufacturing scale.

Through these compounded shifts, the market is experiencing a redefinition of value, where performance metrics extend beyond pharmacokinetics to encompass user experience, ecological impact, and digital interoperability. Stakeholders who adapt to these evolving benchmarks stand to gain enduring differentiation, creating new frontiers for topical therapeutics that balance medical efficacy with holistic patient and environmental considerations.

Analyzing the Broader Implications of New United States Tariff Policies on Topical Drug Manufacturing Supply Chains and Cost Structures for 2025

The introduction of new United States tariff measures slated for 2025 is reshaping the economics of topical drug production and distribution. Manufacturers sourcing active pharmaceutical ingredients and excipients from overseas suppliers are confronting elevated import duties, which cascade through procurement and inventory management processes. These cost pressures are prompting supply chain realignments, as companies reexamine vendor portfolios and assess the viability of nearshoring production to mitigate exposure to tariff volatility.

In turn, contract manufacturing organizations are recalibrating capacity allocation decisions, prioritizing domestic facilities or establishing dual-sourcing strategies to maintain flexibility. Providers that invest in localized excipient synthesis and formulation lines are better positioned to sustain throughput without sacrificing cost competitiveness. Concurrently, strategic procurement teams are negotiating long-term supplier agreements and leveraging hedging mechanisms to stabilize raw material costs in the face of fluctuating duty schedules.

As this tariff environment unfolds, firms that proactively evaluate the total landed cost of goods, coupled with scenario modeling of trade policy impacts, will secure resilience in their operations. By integrating tariff considerations into end-to-end supply chain planning and adopting agile manufacturing frameworks, organizations can navigate regulatory headwinds while maintaining timely delivery of topical therapies to patients in need.

Deep-Dive into Critical Market Segments for Topical Drug Delivery Across Diverse Product Types Technologies Formulations and Therapeutic Applications

A nuanced understanding of market segmentation reveals the granular drivers behind product innovation and commercial adoption. Within topical formulations based on product type, creams differentiate into oil-in-water emulsions and water-in-oil formats, each selected for its distinct skin hydration and barrier modulation profiles. Gels encompass both hydrogel systems prized for their cooling and moisturization attributes and organogel matrices that facilitate lipophilic drug dispersion. Ointments bifurcate into hydrophilic and lipophilic bases, catering to both aqueous and oil-soluble active compounds, while patches range from single-layer constructs suited for immediate release to complex multi-layer assemblies designed for sustained delivery.

Advancements in delivery technology stratify offerings into active and passive platforms, with the former leveraging external stimuli to accelerate permeation and the latter relying on intrinsic formulation properties. Routes of administration extend beyond the dermal surface to include buccal, nasal, ocular, rectal, and vaginal pathways, widening therapeutic applicability. Formulation types traverse the continuum from liquids to semi-solids, solids, and innovative sprays and foams that enhance dosing convenience.

Therapeutic applications further dissect the landscape: dermatology formulations targeted against bacterial, fungal, and inflammatory skin disorders; hormone replacement therapies addressing estrogen and testosterone deficiencies; and pain management options ranging from local anesthetics to nonsteroidal anti-inflammatory drugs. End users span clinics, home healthcare settings, hospitals including both inpatient and outpatient wings, and retail pharmacies, while distribution channels extend through offline conduits such as hospital and retail pharmacies alongside burgeoning online pharmacy platforms. Together, this multi-axis segmentation framework guides R&D prioritization, commercialization strategies, and portfolio optimization efforts.

Exploring Regional Dynamics Shaping the Adoption and Innovation of Topical Therapeutic Solutions Across the Americas EMEA and Asia-Pacific

Regional variations in healthcare infrastructure, regulatory regimes, and patient demographics exert profound influence on topical drug delivery adoption and innovation trajectories. In the Americas, a robust pipeline of dermatological therapies is underpinned by streamlined approval processes and a mature network of specialty clinics that champion advanced formulations. North American reimbursement policies incentivize cost-effective solutions, while Latin American markets are experiencing rising demand for affordable generics and biosimilar topical products driven by expanding public health initiatives.

Across Europe, the Middle East, and Africa, harmonized regulatory frameworks are fostering cross-border collaboration on clinical trials and post-market surveillance, enabling manufacturers to scale distribution more efficiently. Patient preferences in Western European nations are shifting toward personalized topical regimens and bioarchitected polymers, whereas emerging markets within Africa and the Gulf Cooperation Council region are prioritizing essential dermatology and pain management therapies to address unmet needs.

In Asia-Pacific, rapid urbanization and expanding middle-class populations are elevating the uptake of cosmetic-adjacent dermatological solutions, while government support for domestic API production is strengthening local supply chains. Regulatory authorities in Japan, Australia, and Southeast Asian hubs are increasingly aligning with international quality standards, accelerating access to novel transdermal and mucosal delivery platforms. These regional insights illuminate pathways for market entry, partnership development, and targeted commercialization based on localized drivers and system capabilities.

Profiling Leading Industry Players Driving Growth and Differentiation in the Topical Drug Delivery Market Through Strategic Innovation Partnerships and Expansion

Leading industry participants are differentiating through a combination of strategic alliances, proprietary technology platforms, and extensive formulation portfolios. Major pharmaceutical conglomerates are leveraging in-house R&D capabilities to develop next-generation topical systems that integrate sensors or employ responsive release mechanisms. Their global scale and regulatory expertise enable rapid entry into key markets and facilitate complex clinical evaluations.

In parallel, specialized biotechnology firms are forging collaborative partnerships with material science innovators to co-develop hallmark delivery vehicles such as microneedle patches or nanoemulsion carriers. These cooperations often culminate in out-licensing agreements or joint ventures that expand the reach of niche technologies, allowing large-scale manufacturers to license advanced assets without shouldering full development risk.

Contract development and manufacturing organizations have emerged as pivotal enablers of commercialization, offering end-to-end capabilities from molecule screening to commercial lot release. Their modular production platforms cater to both small biotech entrants and established drug makers, providing scalability and regulatory compliance in equal measure. Collectively, these company strategies are elevating the value proposition of topical therapies, fostering a competitive environment that prizes rapid innovation and comprehensive service offerings.

Outlining Strategic Imperatives and Tactical Initiatives for Industry Leaders to Elevate Market Positioning and Operational Efficiency in Topical Delivery

To capitalize on shifting market dynamics, industry leaders must adopt a multifaceted approach that aligns R&D investment with evolving patient and payer priorities. Executives should prioritize development of smart delivery systems that incorporate digital adherence monitoring and responsive release triggers. By forging interdisciplinary teams that blend pharmaceutical scientists, materials engineers, and data analysts, organizations can accelerate proof-of-concept studies and de-risk advanced pipeline candidates.

Supply chain resilience demands that procurement and operations professionals establish dual-sourcing arrangements for critical materials and pursue strategic manufacturing partnerships both domestically and in emerging production hubs. Implementing integrated planning systems that factor in tariff schedules, inventory buffers, and demand signal repositories will enhance agility and cost control. Concurrently, commercial teams should tailor go-to-market strategies to regional reimbursement landscapes, emphasizing value propositions around patient outcomes and total cost of care.

Finally, leadership must foster a culture of continuous innovation by incentivizing intrapreneurial initiatives and leveraging external incubators to scout disruptive formulation concepts. By embedding sustainability metrics and social responsibility objectives into project pipelines, companies can anticipate regulatory trends and strengthen brand reputation. These actionable steps will position organizations to drive growth, maintain competitive differentiation, and deliver impactful topical therapies that resonate with diverse stakeholder groups.

Detailing the Rigorous Research Framework and Analytical Techniques Employing Qualitative and Quantitative Approaches to Ensure Comprehensive Market Insights

The insights presented in this summary are derived from a meticulously structured research protocol combining qualitative and quantitative methodologies. Initial exploratory interviews with key opinion leaders, including dermatologists, pharmacologists, and formulation scientists, provided foundational perspectives on unmet needs and technological barriers. These primary inputs were supplemented by a systematic review of peer-reviewed journals, patent databases, and conference proceedings to capture the latest scientific breakthroughs and regulatory developments.

Quantitative analysis involved a comprehensive mapping of product portfolios, clinical trial registries, and supply chain footprints. Data triangulation techniques were employed to validate information from multiple sources, ensuring a rigorous depiction of competitive landscapes and innovation trajectories. Custom scoring models were developed to assess companies' technological maturity, partnership activity, and market reach, facilitating comparative benchmarking across critical delivery platforms.

Finally, regional case studies and scenario planning exercises were conducted to evaluate the potential impacts of tariff changes and reimbursement shifts on operational resilience. By integrating stakeholder feedback loops at interim stages, the research framework maintained alignment with evolving industry priorities, yielding an authoritative and actionable compendium of topical drug delivery market insights.

Synthesizing Core Findings and Forward-Looking Perspectives to Guide Stakeholders in Navigating Opportunities and Challenges in Topical Drug Delivery

The collective analysis underscores a pivotal moment for topical drug delivery, as converging forces of technological innovation, regulatory evolution, and shifting patient expectations reshape the competitive landscape. Advanced delivery mechanisms are unlocking new therapeutic frontiers, while sustainability and digital integration are redefining value beyond traditional pharmacokinetic parameters. Tariff and trade policy headwinds necessitate adaptive supply chain strategies, underscoring the importance of agility and localized manufacturing.

By dissecting the market through multidimensional segmentation and regional lenses, stakeholders gain clarity on high-priority opportunities-from smart sensor-enabled patches in developed markets to cost-effective generics in emerging regions. A review of company strategies reveals that collaborative ecosystems and end-to-end service models are key differentiators for organizations seeking rapid scale and regulatory compliance. Actionable recommendations stress the imperative of cross-functional innovation teams, resilient sourcing frameworks, and patient-centric value propositions.

Together, these findings offer a cohesive blueprint for pharmaceutical developers, contract organizations, and commercial executives to navigate complexity, harness emerging technologies, and deliver topical therapies that meet both clinical and market demands. Embracing these insights will empower stakeholders to capitalize on the next wave of growth and improve patient outcomes globally.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Advances in nanoemulsion technology to enhance dermal penetration of biologics
  • 5.2. Growing adoption of microneedle patches for pain-free self-administered therapies
  • 5.3. Integration of sustained release polymer matrices in topical wound healing formulations
  • 5.4. Emergence of 3D printing techniques for customizable transdermal drug delivery systems
  • 5.5. Regulatory challenges in harmonizing global guidelines for topical nanocarrier approvals
  • 5.6. Increasing focus on patient-centric design to improve adherence in topical dermatological therapies
  • 5.7. Advancements in peptide stabilization strategies for enhanced skin bioavailability in creams

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Topical Drug Delivery Market, by Product Type

  • 8.1. Introduction
  • 8.2. Creams
    • 8.2.1. Oil In Water
    • 8.2.2. Water In Oil
  • 8.3. Gels
    • 8.3.1. Hydrogel
    • 8.3.2. Organogel
  • 8.4. Ointments
    • 8.4.1. Hydrophilic
    • 8.4.2. Lipophilic
  • 8.5. Patches
    • 8.5.1. Multi Layer
    • 8.5.2. Single Layer

9. Topical Drug Delivery Market, by Delivery Technology

  • 9.1. Introduction
  • 9.2. Active Delivery
  • 9.3. Passive Delivery

10. Topical Drug Delivery Market, by Route of Administration

  • 10.1. Introduction
  • 10.2. Buccal
  • 10.3. Dermal
  • 10.4. Nasal
  • 10.5. Ocular
  • 10.6. Rectal
  • 10.7. Vaginal

11. Topical Drug Delivery Market, by Formulation Type

  • 11.1. Introduction
  • 11.2. Liquids
  • 11.3. Semi-solids
  • 11.4. Solids
  • 11.5. Sprays & Foams

12. Topical Drug Delivery Market, by Therapeutic Application

  • 12.1. Introduction
  • 12.2. Dermatology
    • 12.2.1. Anti Bacterial
    • 12.2.2. Anti Fungal
    • 12.2.3. Anti Inflammatory
  • 12.3. Hormone Replacement
    • 12.3.1. Estrogen
    • 12.3.2. Testosterone
  • 12.4. Pain Management
    • 12.4.1. Local Anesthetics
    • 12.4.2. NSAIDs

13. Topical Drug Delivery Market, by End User

  • 13.1. Introduction
  • 13.2. Clinics
  • 13.3. Home Healthcare
  • 13.4. Hospitals
    • 13.4.1. Inpatient
    • 13.4.2. Outpatient
  • 13.5. Retail Pharmacies

14. Topical Drug Delivery Market, by Distribution Channel

  • 14.1. Introduction
  • 14.2. Offline
    • 14.2.1. Hospital Pharmacy
    • 14.2.2. Retail Pharmacy
  • 14.3. Online Pharmacies

15. Americas Topical Drug Delivery Market

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. Argentina

16. Europe, Middle East & Africa Topical Drug Delivery Market

  • 16.1. Introduction
  • 16.2. United Kingdom
  • 16.3. Germany
  • 16.4. France
  • 16.5. Russia
  • 16.6. Italy
  • 16.7. Spain
  • 16.8. United Arab Emirates
  • 16.9. Saudi Arabia
  • 16.10. South Africa
  • 16.11. Denmark
  • 16.12. Netherlands
  • 16.13. Qatar
  • 16.14. Finland
  • 16.15. Sweden
  • 16.16. Nigeria
  • 16.17. Egypt
  • 16.18. Turkey
  • 16.19. Israel
  • 16.20. Norway
  • 16.21. Poland
  • 16.22. Switzerland

17. Asia-Pacific Topical Drug Delivery Market

  • 17.1. Introduction
  • 17.2. China
  • 17.3. India
  • 17.4. Japan
  • 17.5. Australia
  • 17.6. South Korea
  • 17.7. Indonesia
  • 17.8. Thailand
  • 17.9. Philippines
  • 17.10. Malaysia
  • 17.11. Singapore
  • 17.12. Vietnam
  • 17.13. Taiwan

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. DuPont de Nemours, Inc.
    • 18.3.2. Element Materials Technology
    • 18.3.3. 3M Company
    • 18.3.4. AbbVie Inc.
    • 18.3.5. Bausch Health Companies Inc.
    • 18.3.6. Bayer AG
    • 18.3.7. Crescita Therapeutics Inc.
    • 18.3.8. Galderma SA
    • 18.3.9. GlaxoSmithKline plc
    • 18.3.10. Hisamitsu Pharmaceutical Co.,Inc.
    • 18.3.11. Johnson & Johnson Services, Inc.
    • 18.3.12. Kindeva Drug Delivery L.P.
    • 18.3.13. LEO Pharma A/S
    • 18.3.14. Lubrizol Corporation
    • 18.3.15. MedPharm Group Ltd.
    • 18.3.16. Merck & Co., Inc.
    • 18.3.17. Novartis AG
    • 18.3.18. Pfizer Inc.
    • 18.3.19. Porex Corporation
    • 18.3.20. Sun Pharmaceutical Industries Ltd.

19. ResearchAI

20. ResearchStatistics

21. ResearchContacts

22. ResearchArticles

23. Appendix

LIST OF FIGURES

  • FIGURE 1. TOPICAL DRUG DELIVERY MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 18. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 22. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 26. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 27. TOPICAL DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. TOPICAL DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 29. TOPICAL DRUG DELIVERY MARKET: RESEARCHAI
  • FIGURE 30. TOPICAL DRUG DELIVERY MARKET: RESEARCHSTATISTICS
  • FIGURE 31. TOPICAL DRUG DELIVERY MARKET: RESEARCHCONTACTS
  • FIGURE 32. TOPICAL DRUG DELIVERY MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. TOPICAL DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OIL IN WATER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OIL IN WATER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY WATER IN OIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY WATER IN OIL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HYDROGEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HYDROGEL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ORGANOGEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ORGANOGEL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HYDROPHILIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HYDROPHILIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIPOPHILIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIPOPHILIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY MULTI LAYER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY MULTI LAYER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SINGLE LAYER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SINGLE LAYER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ACTIVE DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ACTIVE DELIVERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PASSIVE DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PASSIVE DELIVERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY BUCCAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY BUCCAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY NASAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY NASAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OCULAR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY RECTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY RECTAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY VAGINAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY VAGINAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUIDS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLIDS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLIDS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SPRAYS & FOAMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SPRAYS & FOAMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ANTI BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ANTI BACTERIAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ANTI FUNGAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ANTI FUNGAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ANTI INFLAMMATORY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ANTI INFLAMMATORY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ESTROGEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ESTROGEN, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TESTOSTERONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TESTOSTERONE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY NSAIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY NSAIDS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY INPATIENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY INPATIENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 111. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 113. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
  • TABLE 115. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 117. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 119. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 121. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 123. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 125. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
  • TABLE 127. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 129. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 131. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2025-2030 (USD MILLION)
  • TABLE 133. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2025-2030 (USD MILLION)
  • TABLE 135. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2025-2030 (USD MILLION)
  • TABLE 137. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2025-2030 (USD MILLION)
  • TABLE 139. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 141. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
  • TABLE 143. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
  • TABLE 145. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 147. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2025-2030 (USD MILLION)
  • TABLE 149. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2025-2030 (USD MILLION)
  • TABLE 151. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 153. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 155. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
  • TABLE 157. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 159. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
  • TABLE 161. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 163. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 165. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2024 (USD MILLION)
  • TABLE 166. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2025-2030 (USD MILLION)
  • TABLE 167. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2024 (USD MILLION)
  • TABLE 168. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2025-2030 (USD MILLION)
  • TABLE 169. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2024 (USD MILLION)
  • TABLE 170. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2025-2030 (USD MILLION)
  • TABLE 171. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2024 (USD MILLION)
  • TABLE 172. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2025-2030 (USD MILLION)
  • TABLE 173. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 174. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 175. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 176. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
  • TABLE 177. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
  • TABLE 179. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 181. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2024 (USD MILLION)
  • TABLE 182. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2025-2030 (USD MILLION)
  • TABLE 183. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 184. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2025-2030 (USD MILLION)
  • TABLE 185. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 186. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 187. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 189. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 190. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
  • TABLE 191. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 192. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 193. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
  • TABLE 194. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
  • TABLE 195. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 196. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 197. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 199. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2024 (USD MILLION)
  • TABLE 200. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2025-2030 (USD MILLION)
  • TABLE 201. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2024 (USD MILLION)
  • TABLE 202. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2025-2030 (USD MILLION)
  • TABLE 203. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2024 (USD MILLION)
  • TABLE 204. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2025-2030 (USD MILLION)
  • TABLE 205. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2024 (USD MILLION)
  • TABLE 206. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2025-2030 (USD MILLION)
  • TABLE 207. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 209. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 210. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
  • TABLE 211. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
  • TABLE 213. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 215. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2024 (USD MILLION)
  • TABLE 216. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2025-2030 (USD MILLION)
  • TABLE 217. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 218. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2025-2030 (USD MILLION)
  • TABLE 219. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 220. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 221. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 223. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 224. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
  • TABLE 225. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 226. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 227. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
  • TABLE 228. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
  • TABLE 229. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 231. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2024 (USD MILLION)
  • TABLE 232. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2025-2030 (USD MILLION)
  • TABLE 233. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2024 (USD MILLION)
  • TABLE 234. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2025-2030 (USD MILLION)
  • TABLE 235. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2024 (USD MILLION)
  • TABLE 236. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2025-2030 (USD MILLION)
  • TABLE 237. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2024 (USD MILLION)
  • TABLE 238. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2025-2030 (USD MILLION)
  • TABLE 239. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 240. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 241. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 242. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
  • TABLE 243. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
  • TABLE 245. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 247. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2025-2030 (USD MILLION)
  • TABLE 249. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 250. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2025-2030 (USD MILLION)
  • TABLE 251. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 252. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 253. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 255. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 256. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
  • TABLE 257. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 258. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 259. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
  • TABLE 260. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
  • TABLE 261. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 263. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2024 (USD MILLION)
  • TABLE 264. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2025-2030 (USD MILLION)
  • TABLE 265. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2024 (USD MILLION)
  • TABLE 266. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2025-2030 (USD MILLION)
  • TABLE 267. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2024 (USD MILLION)
  • TABLE 268. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2025-2030 (USD MILLION)
  • TABLE 269. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2024 (USD MILLION)
  • TABLE 270. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2025-2030 (USD MILLION)
  • TABLE 271. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 272. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 273. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 274. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
  • TABLE 275. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
  • TABLE 277. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 279. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2024 (USD MILLION)
  • TABLE 280. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2025-2030 (USD MILLION)
  • TABLE 281. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 282. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2025-2030 (USD MILLION)
  • TABLE 283. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 284. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 285. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 287. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 288. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
  • TABLE 289. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 290. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 291. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
  • TABLE 292. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
  • TABLE 293. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 295. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2024 (USD MILLION)
  • TABLE 296. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2025-2030 (USD MILLION)
  • TABLE 297. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2024 (USD MILLION)
  • TABLE 298. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2025-2030 (USD MILLION)
  • TABLE 299. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2024 (USD MILLION)
  • TABLE 300. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2025-2030 (USD MILLION)
  • TABLE 301. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2024 (USD MILLION)
  • TABLE 302. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2025-2030 (USD MILLION)
  • TABLE 303. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 304. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 305. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 306. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
  • TABLE 307. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
  • TABLE 309. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 311. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2024 (USD MILLION)
  • TABLE 312. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2025-2030 (USD MILLION)
  • TABLE 313. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 314. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2025-2030 (USD MILLION)
  • TABLE 315. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 316. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
  • TABLE 317. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 319. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 320. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
  • TABLE 321. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 322. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 323. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
  • TABLE 324. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
  • TABLE 325. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 327. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2025-2030 (USD MILLION)
  • TABLE 329. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2025-2030 (USD MILLION)
  • TABLE 331. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2024 (USD MILLION)
  • TABLE 332. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2025-2030 (USD MILLION)
  • TABLE 333. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2024 (USD MILLION)
  • TABLE 334. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCH